FDA Committee Supports Approval of Vantrela ERFDA Committee Supports Approval of Vantrela ER

An FDA committee supports approval of Vantrela ER, an extended-release hydrocodone product for pain management. It also recommends that the labelng for the drug reflect its abuse-deterrence properties. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news